Comparison of an antiviral activity of recombinant consensus interferon with recombinant interferon-α-2b

Microbes and Infection

Volumn 1, Issue 13, 1999, Pages 1073-1077

  Koyama, A Hajime ^a   Arakawa, Tsutomu ^b   Adachi, Akio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b AMGEN INC   (United States)

Author keywords

Antiviral activity; Consensus interferon

Indexed keywords

ALPHA INTERFERON; CONSENSUS INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MACROMOLECULE; NONHUMAN; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS STRAIN;

ANIMALIA; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 0032727119     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00210-5     Document Type: Article

References (13)

1. Cantel K. Developments of antiviral therapy with alpha interferons: Promises, false hopes and accomplishments. Ann. M. 27:1995;23-28.
2. Klein M.L., Bartley T.D., Lai P.H., Lu H.S. Structural characterization of recombinant consensus interferon-α J. Chromatog. 454:1988;205-215.
3. Fish E.N., Banerjee K., Stebbing N. Efficacy of consensus interferon alpha against HSV-2 infections. Antiviral Res. Suppl. 1. 1985;191-197.
4. Altrock B.W., Fagin K.D., Hockman H.R., Fish E.N., Goldstein L., Chang D., Ducker K., Stebbing N. Antiviral and antitumor effects of a human interferon analog, IFN-Con1, assessed in hamsters. J. Interferon Res. 6:1986;405-415.
5. Fish E.N. Definition of receptor binding domains in interferon-α J. Interferon Res. 12:1992;257-266.
6. Ozes O.N., Reiter Z., Klein S., Blatt L.M., Taylor M.W. A comparison of interferon-Con1 with natural recombinant interferons-α: Antiviral, antiproliferative, and natural killer-inducing activities. J. Interferon Res. 12:1992;55-59.
7. Koyama A.H., Uchida T. Inhibition of multiplication of herpes simplex virus type 1 by ammonium chloride and chloroquine. Virology. 138:1984;332-335.
8. Koyama A.H., Miwa Y. Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells. J. Virol. 71:1997;2567-2571.
9. Koyama A.H. Induction of apoptotic DNA fragmentation by the infection of vesicular stomatitis virus. Virus Res. 37:1995;285-290.
10. Klein S.B., Blatt L.M., Taylor M.W. Cell surface binding characteristics correlate with consensus type I interferon enhanced activity. J. Interferon Cytokine Res. 16:1996;1-6.
11. Hu C.J., Ozes O.N., Klein S.B., Blatt L.M., Taylor M.W. Comparison of the in vitro host range of recombinant met-interferon-Con1, interferon-α-2A, and interferon-β J. Interferon Cytokine Res. 15:1995;231-234.
12. Domanski P., Nadeau O.W., Platanias L.C., Fish E., Kellum M., Pitha P., Colamonici O.R. Differential use of the β L subunit of the type I interferon (IFN) receptor determines specificity for IFN α 2 and IFN β J. Biol. Chem. 273:1998;3144-3147.
13. Vilcek J., Sen G.C. Interferon and other cytokines. Fields B.N, Knipe D.M, Howley P.M. Fields Virology. 3rd :1996;375-399 Lippincott-Raven, Philadelphia.